




Scenario: A provincial specialized cancer hospital needed to replace outdated equipment for screening blood samples of non-small cell lung cancer (NSCLC) patients eligible for EGFR-targeted drugs, aiming to optimize treatment plans and improve medication efficiency.
Requirements: The hospital diagnoses over 5,000 lung cancer cases annually with specific testing demands. The Pathology Department mainly conducts EGFR testing on tissue samples, but there is an urgent need for blood ctDNA testing as a supplement for patients who cannot provide tissue samples.
Solution:
With the standard laboratory detection solution provided by Rocgene, the recovery quality and quantity of ctDNA were ensured through targeted blood DNA extraction reagents, and Archimed X6 was adopted for detection to replace the original outdated equipment.
Results:
Upon arrival at the laboratory, ArchiPure32 was used to complete nucleic acid extraction and purification of blood samples. With faster temperature ramping speed and shorter temperature hold time, Archimed X6 reduced the detection time from 90 minutes (original platform) to 75 minutes. Additionally, the light source service life of over 100,000 hours greatly reduced the hospital's usage and subsequent maintenance costs.

